With the coronavirus still wreaking havoc, vaccine stocks are in the spotlight.
To date, Gilead has noted preliminary results of a COVID-19 vaccine trial “showed...
Markets roared higher last week on news Gilead’s (GILD) coronavirus drug produced “rapid” recovery in patients. In fact, a University of Chicago Phase 3...